On the Value of COVID-19 Testing for Children Beyond the Spring of 2021 | Adolescent Medicine | JAMA Network Open | JAMA Network
[Skip to Navigation]
Sign In
Invited Commentary
Public Health
April 23, 2021

On the Value of COVID-19 Testing for Children Beyond the Spring of 2021

Author Affiliations
  • 1PolicyLab, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  • 2Division of General Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  • 3Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • 4Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
JAMA Netw Open. 2021;4(4):e217850. doi:10.1001/jamanetworkopen.2021.7850

As we pass the 1-year anniversary of the start of the COVID-19 pandemic, an analysis by Moghadas and colleagues1 considers the value of frequent testing of schoolchildren in reducing community transmission rates. Certainly, the US and many countries find themselves in a stronger position than they were in 2020. In the US, the pace of vaccinations is increasing, and hospitalizations are now declining in most regions. This will lead some to wonder what value school-based testing can bring in the coming months, particularly during the 2021 to 2022 academic year.

However, it is unlikely that the next academic year will start with classrooms of fully vaccinated children because vaccine trials are just now commencing for elementary school–age children. It is likely that many children will not be offered vaccination until 2022. Furthermore, required vaccination for school entry is unlikely to be considered widely until full US Food and Drug Administration approval has been granted (the vaccines are currently being used under a Food and Drug Administration emergency use authorization).

With increasing vaccinations of adults, we should nevertheless anticipate that the next academic year will return our youth to normal school days with full-time in-school instruction, even if not all have been vaccinated. The lower risk of severe disease in children and adolescents, and adequate protection of older individuals, will likely make these decisions straightforward. However, a growing reservoir of variant strains and continued vaccine hesitancy may create uncertainty about the safety of crowded classrooms, particularly if the country experiences a higher than expected 2021 to 2022 seasonal peak in SARS-CoV-2 transmission. Although the growing proportion of the population with immunity, from either natural infection or vaccination, is likely to blunt the anticipated peak in COVID-19 infections next winter, some communities and their schools will want additional measures of safety in place as contingency plans if winter transmission rates surpass expectations. Such is the nature of COVID-19 becoming an endemic infection, likely to join influenza as 1 of 2 primary respiratory viruses of concern each winter.2 SARS-CoV-2 may become less virulent than it was at the onset of the pandemic because of increasing immunological memory in the population or acquired mutations among variants that may favor increased transmissibility over increased virulence, but it may likely continue to add burdens to our hospitals each year, particularly for older adults.

In this regard, the analysis by Moghadas et al1 is particularly relevant. Through a very thoughtful simulation, the authors consider minimum thresholds of detecting early infections in children in order for communities to keep transmission at bay (defined as an attack rate <5%). The authors estimate that detecting only 10% to 20% of such infections in schoolchildren within the first 3 days after onset of infection may be enough to prevent widespread community transmission, assuming that a majority of adults are vaccinated in the area.1

As leaders of a large regional school-based testing initiative, Project ACE-IT, in the Southeast region of Pennsylvania, we cannot understate the value of these findings. Partnering with the US Department of Health and Human Services and the Centers for Disease Control and Prevention to deliver weekly testing to staff and students during the second half of the 2020 to 2021 academic year, we have seen firsthand how challenging it is to deliver school-based testing to reduce school-related transmission among staff and students. Weekly surveillance testing (ie, assurance testing) has, in large part, remained voluntary, in contrast to the required participation that many colleges and universities have imposed on their students, a now-proven strategy to achieve consistent viral reduction over time.3 In our region, some kindergarten through grade 12 teachers and families have opted out of testing, and many school leaders have been reluctant to require testing beyond those children participating in scholastic sports or extracurricular activities, given the uncertainty of legal authority for mandatory testing for all staff and students. This has led some to question the added utility of testing students and staff weekly, if there is a large group that is not participating.

What the study by Moghadas et al1 reveals to us is that we should not allow the perfect to be the enemy of the good. Weekly assurance testing may still be valuable despite incomplete participation. The goal of a strong school-based testing program is both assuring the community that schools can be safe and achieving a modest viral reduction by identifying some of the potentially contagious individuals early and thereby preventing in-school exposures. Short of full participation, this analysis1 reveals that from a public health perspective, viral reduction on the margins can be extremely valuable, particularly as vaccine coverage grows in other areas of the community. Yes, we should encourage and incentivize full participation in such testing programs but we should not abandon them if some opt out.

Ultimately, this analysis by Moghadas et al1 reveals the potential benefit of using school-based testing, even in the face of widespread adult vaccination, to minimize risk to communities as schools repopulate following the COVID-19 pandemic. The goal of 10% to 20% reduction of early contagious individuals in schools is attainable and can help persuade participation by reluctant school districts that may be building back their school-based health programs after years of neglect. The world has suffered greatly since early 2020, but there are lessons that will endure past this epidemic, and we can only hope that school-based testing for transmittable disease will grow and be sustained after the pandemic is beyond its worst days. The article by Moghadas et al1 gives us a vision for what that might look like, and it is one that can occur in parallel to schools resuming normally next year, with limited disruption from other safety protocols of the COVID-19 pandemic year.

Back to top
Article Information

Published: April 23, 2021. doi:10.1001/jamanetworkopen.2021.7850

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Rubin D et al. JAMA Network Open.

Corresponding Author: David Rubin, MD, MSCE, PolicyLab, Children’s Hospital of Philadelphia, 2716 South St, Roberts Bldg, CHOP North, Ste 10123, Philadelphia, PA 19103 (rubin@chop.edu).

Conflict of Interest Disclosures: Dr Coffin reported being a member of a data safety monitoring board for Clostridium difficile therapy research done by Merck & Co and serving as an advisor to Genentech about pediatric therapies for COVID. No other disclosures were reported.

References
1.
Moghadas  SM, Fitzpatrick  MC, Shoukat  A, Zhang  K, Galvani  AP.  Simulated identification of silent COVID-19 infections among children and estimated future infection rates with vaccination.   JAMA Netw Open. 2021;4(4):e217097. doi:10.1001/jamanetworkopen.2021.7097Google Scholar
2.
Murray  CJL, Piot  P.  The potential future of the COVID-19 pandemic: will SARS-CoV-2 become a recurrent seasonal infection?   JAMA. Published online March 3, 2021. doi:10.1001/jama.2021.2828PubMedGoogle Scholar
3.
Paltiel  AD, Zheng  A, Walensky  RP.  Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States.   JAMA Netw Open. 2020;3(7):e2016818. doi:10.1001/jamanetworkopen.2020.16818PubMedGoogle Scholar
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    1 Comment for this article
    EXPAND ALL
    Covid-19 Antigen Serial Testing Scheme
    KS Lam, MBA | Pharmaceutical Statistical Analyst
    The Centers for Disease Control and Prevention (CDC) has released updated testing guidance to ramp up screening testing of asymptomatic students without known exposure so as to help schools reopen [1]. CDC said that "Achieving substantial reduction in transmission with testing requires more frequent testing and shorter lags between test administration and reporting of results".

    The Food and Drug Administration (FDA) last month streamlined the path to emergency use authorization (EUA) for screening tests [2]. The recommendations apply to test developers who seek an EUA from the FDA for asymptomatic screening tests with serial testing. FDA also has released a fact sheet to
    assist schools, workplaces, communities, and others looking to establish testing programs to screen asymptomatic individuals as they are selecting a test for screening [3]. Together these coordinated actions are intended to expand the availability of tests authorized for screening asymptomatic individuals frequently.

    Antigen tests are relatively less expensive than RT-PCR, and most can be used at the point of care and home. Antigen tests remain controversial however because they are less sensitive than RT-PCR tests especially among asymptomatic people. Modeling studies have suggested that if the frequency of testing is high enough, even tests with lower sensitivity could be successfully used to reduce cumulative infection rates [4]. In essence, detecting infectious asymptomatic people is key to break the chain of onward transmission.

    What are the statistical implications of serial testing impact? FDA recommends that individuals test twice within 24-36 hours. Assuming the antigen test has 80% sensitivity and 99% specificity and the moderate community prevalence is 5%, the NPV and PPV estimated in the first antigen test are 81% and 99%. About 20% false positive results are therefore anticipated. After a sequential antigen testing, both NPV and PPV are estimated near 100%. Consequently, there are no false results. In this context, a serial antigen testing scheme does enhance its ability to identify COVID-19 correctly.    

    In conclusion, accelerating the use of a serial testing scheme to reopen schools is a promising strategy. This potential can only be fully realized if we will change our mindset [5].

    References:

    1. Operational Strategy for K-12 Schools through Phased Prevention
    https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/operation-strategy.html

    2. Pathway Eased for Serial COVID-19 Screening Tests https://jamanetwork.com/journals/jama/fullarticle/2778822

    3. Screening for COVID-19: Deciding Which Test to Use When Establishing Testing Programs https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/screening-covid-19-deciding-which-test-use-when-establishing-testing-programs

    4. Paltiel AD, Zheng A, Walensky RP. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. 
    https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2768923

    5. Rethinking Covid-19 Test Sensitivity — A Strategy for Containment
    https://www.nejm.org/doi/10.1056/NEJMp2025631?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
    CONFLICT OF INTEREST: None Reported
    READ MORE
    ×